The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2017 | Exciting current CLL trials taking place in the UK
Peter Hillmen, MD, PhD, from the University of Leeds, Leeds, UK, discusses the current trials on chronic lymphocytic leukemia (CLL) that are taking place in the UK, including the Phase II Bloodwise TAP trials. He notes that one exciting drug combination for CLL treatment is ibrutinib and venetoclax, which is now undergoing a large Phase III trial that is the largest trial ever conducted for CLL. This video was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY.
